Inhibition of RORα/γ suppresses atherosclerosis via inhibition of both cholesterol absorption and inflammation by Cyrielle Billon, Sadichha Sitaula, Thomas P. Burris

Connect to this object online.

The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis by Kristine Griffett, Ryan D. Welch, Colin A. Flaveny, Grant R. Kolar, Brent A. Neuschwander-Tetri, Thomas P. Burris

Connect to this object online.

REV-ERB activation as a novel pharmacological approach for treating inflammatory pain by Sangeet Makhija, Joshua D. Griffett, Giri Babu Veerakanellore, Giri Babu Veerakanellore, Thomas P. Burris, Bahaa Elgendy, Bahaa Elgendy, Kristine Griffett

Connect to this object online.

Rev-Erb co-regulates muscle regeneration via tethered interaction with the NF-Y cistrome by Ryan D. Welch, Chun Guo, Monideepa Sengupta, Katherine J. Carpenter, Natalie A. Stephens, Stacy A. Arnett, Marvin J. Meyers, Lauren M. Sparks, Steven R. Smith, Jinsong Zhang, Thomas P. Burris, Colin A. Flaveny

Connect to this object online.

Adropin: An endocrine link between the biological clock and cholesterol homeostasis by Sarbani Ghoshal, Joseph R. Stevens, Cyrielle Billon, Clemence Girardet, Sadichha Sitaula, Arthur S. Leon, D.C. Rao, James S. Skinner, Tuomo Rankinen, Claude Bouchard, Marinelle V. Nuñez, Kimber L. Stanhope, Deborah A. Howatt, Alan Daugherty, Jinsong Zhang, Matthew Schuelke, Edward P. Weiss, Alisha R. Coffey, Brian J. Bennett, Praveen Sethupathy, Thomas P. Burris, Peter J. Havel, Andrew A. Butler

Connect to this object online.